RU2608932C2 - Раствор элюента - Google Patents

Раствор элюента Download PDF

Info

Publication number
RU2608932C2
RU2608932C2 RU2013126979A RU2013126979A RU2608932C2 RU 2608932 C2 RU2608932 C2 RU 2608932C2 RU 2013126979 A RU2013126979 A RU 2013126979A RU 2013126979 A RU2013126979 A RU 2013126979A RU 2608932 C2 RU2608932 C2 RU 2608932C2
Authority
RU
Russia
Prior art keywords
eluent
solution
eluent solution
reaction
exchange column
Prior art date
Application number
RU2013126979A
Other languages
English (en)
Russian (ru)
Other versions
RU2013126979A (ru
Inventor
Торильд ВИКСТРОМ
Андерс СВАДБЕРГ
Оле Кристиан ХЬЕЛЬСТУЕН
Даг М. ЭВЬЕ
Лиане ОКСЕНФЕЛЬД
Original Assignee
ДжиИ ХЕЛТКЕР ЛИМИТЕД
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ДжиИ ХЕЛТКЕР ЛИМИТЕД filed Critical ДжиИ ХЕЛТКЕР ЛИМИТЕД
Publication of RU2013126979A publication Critical patent/RU2013126979A/ru
Application granted granted Critical
Publication of RU2608932C2 publication Critical patent/RU2608932C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B9/00—General methods of preparing halides
    • C01B9/08—Fluorides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/363—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2013126979A 2010-12-29 2011-12-21 Раствор элюента RU2608932C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061427839P 2010-12-29 2010-12-29
US61/427,839 2010-12-29
PCT/EP2011/073670 WO2012089594A1 (en) 2010-12-29 2011-12-21 Eluent solution

Publications (2)

Publication Number Publication Date
RU2013126979A RU2013126979A (ru) 2015-03-20
RU2608932C2 true RU2608932C2 (ru) 2017-01-26

Family

ID=45495902

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2013126979A RU2608932C2 (ru) 2010-12-29 2011-12-21 Раствор элюента

Country Status (16)

Country Link
US (3) US11504430B2 (enExample)
EP (2) EP2658831B1 (enExample)
JP (1) JP6018581B2 (enExample)
KR (3) KR20130132892A (enExample)
CN (2) CN103270004A (enExample)
AU (1) AU2011351550B2 (enExample)
BR (2) BR112013015396B1 (enExample)
CA (1) CA2823063C (enExample)
DK (3) DK2658831T3 (enExample)
ES (2) ES2621950T3 (enExample)
MX (1) MX363538B (enExample)
PL (2) PL2658831T3 (enExample)
PT (2) PT2793954T (enExample)
RU (1) RU2608932C2 (enExample)
SG (1) SG10201805198TA (enExample)
WO (1) WO2012089594A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130132892A (ko) * 2010-12-29 2013-12-05 지이 헬쓰케어 리미티드 용리제 용액
CA2852840A1 (en) * 2011-10-19 2013-04-25 Piramal Imaging Sa Improved method for production of f-18 labeled a.beta. ligands
JP6446268B2 (ja) * 2011-12-21 2018-12-26 ジーイー・ヘルスケア・リミテッド クエン酸緩衝液中の１８ｆ−フルシクロビン組成物
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201214220D0 (en) * 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
ES3005832T3 (en) 2013-11-13 2025-03-17 Ge Healthcare Ltd Dual run cassette for the synthesis of 18f-labelled compounds
WO2015143019A2 (en) * 2014-03-18 2015-09-24 Mayo Foundation For Medical Education And Research Gaseous f-18 technologies
NL2014828B1 (en) * 2015-05-20 2017-01-31 Out And Out Chemistry S P R L Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method.
JP6827709B2 (ja) * 2016-04-25 2021-02-10 日本メジフィジックス株式会社 ２−［１８ｆ］フルオロ−２−デオキシ−ｄ−グルコースの製造方法
US10695450B2 (en) 2016-07-26 2020-06-30 Laboratoires Cyclopharma Synthesis of a radioactive agent composition
JP7148121B2 (ja) * 2018-08-31 2022-10-05 国立大学法人北海道大学 放射性核種１８ｆの精製方法
GB202005282D0 (en) 2020-04-09 2020-05-27 Blue Earth Diagnostics Ltd Pharmaceutical Formulations
US20230390426A1 (en) * 2020-10-22 2023-12-07 Nihon Medi-Physics Co., Ltd. Method for producing radioactive zirconium complex
JP7127164B2 (ja) * 2021-01-19 2022-08-29 日本メジフィジックス株式会社 ２－［１８ｆ］フルオロ－２－デオキシ－ｄ－グルコースの製造方法
CN113372399A (zh) * 2021-06-04 2021-09-10 江苏华益科技有限公司 一种氟[18f]脱氧葡糖注射液的合成方法
CN119591463B (zh) * 2024-11-27 2025-12-09 遵义医科大学 一种 [18f] 三氟甲基末端烯烃的放射性标记方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5425063A (en) * 1993-04-05 1995-06-13 Associated Universities, Inc. Method for selective recovery of PET-usable quantities of [18 F] fluoride and [13 N] nitrate/nitrite from a single irradiation of low-enriched [18 O] water
RU2165266C1 (ru) * 2000-06-28 2001-04-20 Центральный научно-исследовательский рентгенорадиологический институт Способ получения [2-18f]-2-дезоксиглюкозы
WO2010060694A1 (en) * 2008-10-20 2010-06-03 Hammersmith Imanet Limited Radiofluorination
US20100150835A1 (en) * 2007-02-27 2010-06-17 Bengt Langstrom Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate
RU2394040C2 (ru) * 2004-11-19 2010-07-10 Джи-И Хеликер Лимитед Способ фторирования для синтеза 2-[18f]-фтор-2-дезокси-d-глюкозы
US20100226853A1 (en) * 2007-10-04 2010-09-09 Veach Darren R Fluorine-18 derivatives of dasatinib and uses thereof
US20100243972A1 (en) * 2007-04-23 2010-09-30 Trasis S.A. Method for the preparation of reactive [18] f fluoride
US20100261931A1 (en) * 2007-12-19 2010-10-14 Nihon Medi-Physics Co., Ltd. Process for production of radioactive-fluorine-labeled organic compound

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978758B (en) * 1996-10-02 1999-03-30 Du Pont Merck Pharma Technetium-99m-labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
EP1356827A1 (en) 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
BR0215913A (pt) 2002-11-05 2005-08-09 Ion Beam Applic Sa Composição de radiofármacos rotulados com 18-f e processo para obtê-los
GB0422004D0 (en) * 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
US7235216B2 (en) * 2005-05-01 2007-06-26 Iba Molecular North America, Inc. Apparatus and method for producing radiopharmaceuticals
GB0524851D0 (en) * 2005-12-06 2006-01-11 Ge Healthcare Ltd Radiolabelling method using polymers
WO2007148088A2 (en) * 2006-06-21 2007-12-27 Ge Healthcare Limited Radiopharmaceutical products
US20100056826A1 (en) 2006-11-09 2010-03-04 Nihon Medi-Physicis Co., Ltd. Radioactive diagnostic imaging agent
US8790620B2 (en) 2006-12-21 2014-07-29 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
EP2119458B9 (en) 2007-02-13 2013-08-21 Nihon Medi-Physics Co., Ltd. Method for production of radiation diagnostic imaging agent
EP2017359A3 (en) * 2007-06-11 2009-08-05 Trasis S.A. Method for the elution of 18F fluoride trapped on an anion-exchange resin in a form suitable for efficient radiolabeling without any evaporation step
KR101009712B1 (ko) 2007-02-22 2011-01-19 재단법인 아산사회복지재단 양성자성 용매와 이에 녹는 염들을 이용한 음이온 교환고분자 지지체로부터의 플루오린-18 플루오라이드 용리와이를 이용한 플루오린-18의 표지방법
US20090171272A1 (en) 2007-12-29 2009-07-02 Tegg Troy T Deflectable sheath and catheter assembly
EP2238074A2 (en) * 2008-01-03 2010-10-13 GE Healthcare UK Limited Fluoride processing method
EP2110367A1 (en) * 2008-04-14 2009-10-21 Bayer Schering Pharma Aktiengesellschaft Purification strategy for direct nucleophilic procedures
CN102239130A (zh) * 2008-12-04 2011-11-09 拜耳先灵医药股份有限公司 放射性同位素标记的赖氨酸和鸟氨酸衍生物、它们的用途和制备方法
TW201033713A (en) 2009-03-03 2010-09-16 Wintek Corp Reflective color-changing liquid crystal display
CA2801530C (en) * 2010-06-04 2017-09-12 Piramal Imaging Sa Method for production of f-18 labeled amyloid beta ligands
KR20130132892A (ko) * 2010-12-29 2013-12-05 지이 헬쓰케어 리미티드 용리제 용액
GB201214220D0 (en) * 2012-08-09 2012-09-19 Ge Healthcare Ltd Radiosynthesis

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5425063A (en) * 1993-04-05 1995-06-13 Associated Universities, Inc. Method for selective recovery of PET-usable quantities of [18 F] fluoride and [13 N] nitrate/nitrite from a single irradiation of low-enriched [18 O] water
RU2165266C1 (ru) * 2000-06-28 2001-04-20 Центральный научно-исследовательский рентгенорадиологический институт Способ получения [2-18f]-2-дезоксиглюкозы
RU2394040C2 (ru) * 2004-11-19 2010-07-10 Джи-И Хеликер Лимитед Способ фторирования для синтеза 2-[18f]-фтор-2-дезокси-d-глюкозы
US20100150835A1 (en) * 2007-02-27 2010-06-17 Bengt Langstrom Synthesis of [18F] Fluoromethyl Benzene Using Benzyl Pentafluorobenzenesulfonate
US20100243972A1 (en) * 2007-04-23 2010-09-30 Trasis S.A. Method for the preparation of reactive [18] f fluoride
US20100226853A1 (en) * 2007-10-04 2010-09-09 Veach Darren R Fluorine-18 derivatives of dasatinib and uses thereof
US20100261931A1 (en) * 2007-12-19 2010-10-14 Nihon Medi-Physics Co., Ltd. Process for production of radioactive-fluorine-labeled organic compound
WO2010060694A1 (en) * 2008-10-20 2010-06-03 Hammersmith Imanet Limited Radiofluorination

Also Published As

Publication number Publication date
US20190192660A1 (en) 2019-06-27
ES2621950T3 (es) 2017-07-05
EP2658831B1 (en) 2017-02-15
PL3766522T3 (pl) 2022-07-04
DK3766522T3 (da) 2022-06-13
WO2012089594A1 (en) 2012-07-05
EP3766522B1 (en) 2022-03-23
CA2823063A1 (en) 2012-07-05
CA2823063C (en) 2020-08-11
MX2013007699A (es) 2013-08-15
BR112014015042A2 (pt) 2017-06-13
US20230068052A1 (en) 2023-03-02
JP6018581B2 (ja) 2016-11-02
ES2917875T3 (es) 2022-07-12
BR112014015042B1 (pt) 2021-10-26
DK2658831T3 (en) 2017-04-24
BR112013015396A2 (pt) 2016-09-20
SG10201805198TA (en) 2018-07-30
PL2658831T3 (pl) 2017-07-31
PT2793954T (pt) 2021-01-06
JP2014508731A (ja) 2014-04-10
BR112013015396B1 (pt) 2021-11-03
KR102218263B1 (ko) 2021-02-22
KR20190008994A (ko) 2019-01-25
RU2013126979A (ru) 2015-03-20
KR102137348B1 (ko) 2020-07-23
US11504430B2 (en) 2022-11-22
EP3766522A1 (en) 2021-01-20
BR112014015042A8 (pt) 2017-07-04
AU2011351550B2 (en) 2017-02-02
CN108218650A (zh) 2018-06-29
US20130324715A1 (en) 2013-12-05
AU2011351550A1 (en) 2013-07-25
MX363538B (es) 2019-03-27
DK2793954T3 (da) 2021-01-04
PT3766522T (pt) 2022-06-14
CN103270004A (zh) 2013-08-28
EP2658831A1 (en) 2013-11-06
KR20130132892A (ko) 2013-12-05
KR20190119673A (ko) 2019-10-22

Similar Documents

Publication Publication Date Title
US20230068052A1 (en) Eluent solution
US20160257622A1 (en) Dual run cassette for the synthesis of 18f-labelled compounds
US11077216B2 (en) Formulation and method of synthesis
US10023525B2 (en) Preparation of 18F-fluciclovine
US10662125B2 (en) PET tracer purification system
Svadberg et al. Degradation of acetonitrile in eluent solutions for [18F] fluoride PET chemistry: impact on radiosynthesis of [18F] FACBC and [18F] FDG
US20150231249A1 (en) 18f-fluciclovine compositions in citrate buffers
JP7424574B2 (ja) 放射性フッ素標識化合物の製造方法及び放射性医薬組成物の製造方法
US20220001034A1 (en) Novel formulation and method of synthesis
WO2007066567A1 (ja) 放射性フッ素標識有機化合物の製造方法
WO2025114063A1 (en) Stabilized method for 18f-labeling
EP4559890A1 (en) Stabilized method for 18f-labeling